DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System.
In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020 across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.
Comment: this is good news for everyone, except perhaps the big Pharma companies, as this is a very inexpensive treatment. That might explain the organized resistance to it's acceptance as a viable treatment. Just no money in it. Perhaps Dr. Fauci and his connections to the drug business needs looking into. He has dismissed the use of this drug from the start. A fair question to the good doctor would be "do you have a dog in this fight?"
Click Subscribe at top of this page to have Canadian Sentinel in your inbox.
Comments
Post a Comment
Pending moderation, your comment will be published. Thank You